MedTrace Logo

A Randomized Trial to Prevent HIV Among Gay Couples

NCT03189394 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 600

Last updated 2018-12-11

No results posted yet for this study

Summary

The proposed study is a randomized controlled intervention to reduce sexual risk for HIV among HIV-negative concordant and HIV discordant gay couples. There are three arms of the study: 1) the in-person experimental condition, PRIDE, 2) the online adaptation of the experimental condition, ePRIDE, and 3) the time- and attention-matched in-person control condition, Men's Health. Participants (N = 300 couples) will be randomized equally into one of the three study conditions and assessed via surveys at baseline and at 3-, 6- and 9-months after completion of the intervention sessions.

Conditions

  • HIV Infections

Interventions

BEHAVIORAL

PRIDE

A couples curriculum that is relationship-focused and in-person, aimed at helping to reduce the odds of a composite HIV risk variable among gay couples.

BEHAVIORAL

ePRIDE

A couples curriculum that is relationship-focused and online, aimed at helping to reduce the odds of a composite HIV risk variable among gay couples.

BEHAVIORAL

Men's Health

A men's health curriculum that is individualized and in-person, aimed at helping participants to focus on gay men's health.

Sponsors & Collaborators

Principal Investigators

  • Colleen Hoff, PhD · CREGS, San Francisco State University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-01
Primary Completion
2021-09-01
Completion
2022-09-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03189394 on ClinicalTrials.gov